The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gefitinib API Market Research Report 2025
Synopsis
It is a white powder with anti - tumor and anti - mitosis effect. The molecular formula is C22H24ClFN4O3, CAS number is 184475-35-2.
The global Gefitinib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gefitinib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gefitinib API.
Report Scope
The Gefitinib API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gefitinib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gefitinib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Scion Pharm Taiwan
Farmhispania Group
Chem Genix
Jeil Pharmaceutical
Zhuhai Rundu Pharma
Cipla
Brawn Laboratories
Nischem International
Zhejiang Hisun Pharmaceutical
Qilu Pharmaceutial
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Gefitinib Tablets
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gefitinib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Gefitinib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Gefitinib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
It is a white powder with anti - tumor and anti - mitosis effect. The molecular formula is C22H24ClFN4O3, CAS number is 184475-35-2.
The global Gefitinib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gefitinib API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gefitinib API.
Report Scope
The Gefitinib API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gefitinib API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gefitinib API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Scion Pharm Taiwan
Farmhispania Group
Chem Genix
Jeil Pharmaceutical
Zhuhai Rundu Pharma
Cipla
Brawn Laboratories
Nischem International
Zhejiang Hisun Pharmaceutical
Qilu Pharmaceutial
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Gefitinib Tablets
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gefitinib API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Gefitinib API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Gefitinib API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Gefitinib API Market Overview
1.1 Product Definition
1.2 Gefitinib API Segment by Type
1.2.1 Global Gefitinib API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Gefitinib API Segment by Application
1.3.1 Global Gefitinib API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Gefitinib Tablets
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Gefitinib API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Gefitinib API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Gefitinib API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Gefitinib API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Gefitinib API Production Market Share by Manufacturers (2019-2024)
2.2 Global Gefitinib API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Gefitinib API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Gefitinib API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Gefitinib API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Gefitinib API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Gefitinib API, Product Offered and Application
2.8 Global Key Manufacturers of Gefitinib API, Date of Enter into This Industry
2.9 Gefitinib API Market Competitive Situation and Trends
2.9.1 Gefitinib API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Gefitinib API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Gefitinib API Production by Region
3.1 Global Gefitinib API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Gefitinib API Production Value by Region (2019-2030)
3.2.1 Global Gefitinib API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Gefitinib API by Region (2025-2030)
3.3 Global Gefitinib API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Gefitinib API Production by Region (2019-2030)
3.4.1 Global Gefitinib API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Gefitinib API by Region (2025-2030)
3.5 Global Gefitinib API Market Price Analysis by Region (2019-2024)
3.6 Global Gefitinib API Production and Value, Year-over-Year Growth
3.6.1 North America Gefitinib API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Gefitinib API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Gefitinib API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Gefitinib API Production Value Estimates and Forecasts (2019-2030)
4 Gefitinib API Consumption by Region
4.1 Global Gefitinib API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Gefitinib API Consumption by Region (2019-2030)
4.2.1 Global Gefitinib API Consumption by Region (2019-2024)
4.2.2 Global Gefitinib API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Gefitinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Gefitinib API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Gefitinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Gefitinib API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Gefitinib API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Gefitinib API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Gefitinib API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Gefitinib API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Gefitinib API Production by Type (2019-2030)
5.1.1 Global Gefitinib API Production by Type (2019-2024)
5.1.2 Global Gefitinib API Production by Type (2025-2030)
5.1.3 Global Gefitinib API Production Market Share by Type (2019-2030)
5.2 Global Gefitinib API Production Value by Type (2019-2030)
5.2.1 Global Gefitinib API Production Value by Type (2019-2024)
5.2.2 Global Gefitinib API Production Value by Type (2025-2030)
5.2.3 Global Gefitinib API Production Value Market Share by Type (2019-2030)
5.3 Global Gefitinib API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Gefitinib API Production by Application (2019-2030)
6.1.1 Global Gefitinib API Production by Application (2019-2024)
6.1.2 Global Gefitinib API Production by Application (2025-2030)
6.1.3 Global Gefitinib API Production Market Share by Application (2019-2030)
6.2 Global Gefitinib API Production Value by Application (2019-2030)
6.2.1 Global Gefitinib API Production Value by Application (2019-2024)
6.2.2 Global Gefitinib API Production Value by Application (2025-2030)
6.2.3 Global Gefitinib API Production Value Market Share by Application (2019-2030)
6.3 Global Gefitinib API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Scion Pharm Taiwan
7.1.1 Scion Pharm Taiwan Gefitinib API Corporation Information
7.1.2 Scion Pharm Taiwan Gefitinib API Product Portfolio
7.1.3 Scion Pharm Taiwan Gefitinib API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Scion Pharm Taiwan Main Business and Markets Served
7.1.5 Scion Pharm Taiwan Recent Developments/Updates
7.2 Farmhispania Group
7.2.1 Farmhispania Group Gefitinib API Corporation Information
7.2.2 Farmhispania Group Gefitinib API Product Portfolio
7.2.3 Farmhispania Group Gefitinib API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Farmhispania Group Main Business and Markets Served
7.2.5 Farmhispania Group Recent Developments/Updates
7.3 Chem Genix
7.3.1 Chem Genix Gefitinib API Corporation Information
7.3.2 Chem Genix Gefitinib API Product Portfolio
7.3.3 Chem Genix Gefitinib API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Chem Genix Main Business and Markets Served
7.3.5 Chem Genix Recent Developments/Updates
7.4 Jeil Pharmaceutical
7.4.1 Jeil Pharmaceutical Gefitinib API Corporation Information
7.4.2 Jeil Pharmaceutical Gefitinib API Product Portfolio
7.4.3 Jeil Pharmaceutical Gefitinib API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Jeil Pharmaceutical Main Business and Markets Served
7.4.5 Jeil Pharmaceutical Recent Developments/Updates
7.5 Zhuhai Rundu Pharma
7.5.1 Zhuhai Rundu Pharma Gefitinib API Corporation Information
7.5.2 Zhuhai Rundu Pharma Gefitinib API Product Portfolio
7.5.3 Zhuhai Rundu Pharma Gefitinib API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Zhuhai Rundu Pharma Main Business and Markets Served
7.5.5 Zhuhai Rundu Pharma Recent Developments/Updates
7.6 Cipla
7.6.1 Cipla Gefitinib API Corporation Information
7.6.2 Cipla Gefitinib API Product Portfolio
7.6.3 Cipla Gefitinib API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Cipla Main Business and Markets Served
7.6.5 Cipla Recent Developments/Updates
7.7 Brawn Laboratories
7.7.1 Brawn Laboratories Gefitinib API Corporation Information
7.7.2 Brawn Laboratories Gefitinib API Product Portfolio
7.7.3 Brawn Laboratories Gefitinib API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Brawn Laboratories Main Business and Markets Served
7.7.5 Brawn Laboratories Recent Developments/Updates
7.8 Nischem International
7.8.1 Nischem International Gefitinib API Corporation Information
7.8.2 Nischem International Gefitinib API Product Portfolio
7.8.3 Nischem International Gefitinib API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Nischem International Main Business and Markets Served
7.7.5 Nischem International Recent Developments/Updates
7.9 Zhejiang Hisun Pharmaceutical
7.9.1 Zhejiang Hisun Pharmaceutical Gefitinib API Corporation Information
7.9.2 Zhejiang Hisun Pharmaceutical Gefitinib API Product Portfolio
7.9.3 Zhejiang Hisun Pharmaceutical Gefitinib API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Zhejiang Hisun Pharmaceutical Main Business and Markets Served
7.9.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
7.10 Qilu Pharmaceutial
7.10.1 Qilu Pharmaceutial Gefitinib API Corporation Information
7.10.2 Qilu Pharmaceutial Gefitinib API Product Portfolio
7.10.3 Qilu Pharmaceutial Gefitinib API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Qilu Pharmaceutial Main Business and Markets Served
7.10.5 Qilu Pharmaceutial Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Gefitinib API Industry Chain Analysis
8.2 Gefitinib API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Gefitinib API Production Mode & Process
8.4 Gefitinib API Sales and Marketing
8.4.1 Gefitinib API Sales Channels
8.4.2 Gefitinib API Distributors
8.5 Gefitinib API Customers
9 Gefitinib API Market Dynamics
9.1 Gefitinib API Industry Trends
9.2 Gefitinib API Market Drivers
9.3 Gefitinib API Market Challenges
9.4 Gefitinib API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
